会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 86. 发明申请
    • Acetabular Shell System and Method for Making
    • 髋臼壳系统及制作方法
    • US20100136214A1
    • 2010-06-03
    • US12697847
    • 2010-02-01
    • Mukesh Kumar
    • Mukesh Kumar
    • A61L27/32
    • A61L27/306
    • A method for forming an acetabular shell includes providing a working surface such as a mandrel, and spraying the working surface with a first layer of material having a first composition such as aluminum oxide. After a suitable thickness is generated, the spray composition is gradually changed to other compositions having desired particle sizes and distribution. In one example, the composition is changed to a mixture of aluminum oxide and titanium oxide and/or titanium. As thickness builds up, the relative amount of aluminum oxide is decreased such that the composition is all titanium and titanium oxide. After a desired thickness is generated, the acetabular shell is extracted off the mandrel.
    • 用于形成髋臼壳的方法包括提供诸如心轴的工作表面,以及用第一组合物如氧化铝的第一层材料喷涂工作表面。 在产生合适的厚度之后,将喷雾组合物逐渐变为具有所需粒度和分布的其它组合物。 在一个实例中,将组合物改变为氧化铝和氧化钛和/或钛的混合物。 随着厚度的增加,氧化铝的相对量降低,使得组合物全部为钛和氧化钛。 在产生期望的厚度之后,将髋臼壳从芯轴上取出。
    • 90. 发明授权
    • Genetic adjuvants for immunotherapy
    • 用于免疫治疗的遗传佐剂
    • US07595303B1
    • 2009-09-29
    • US10655873
    • 2003-09-05
    • Shyam S. MohapatraMukesh Kumar
    • Shyam S. MohapatraMukesh Kumar
    • A61K48/00A01N63/00
    • A61K38/217A61K38/208A61K39/35A61K39/36A61K39/39A61K2039/53A61K2039/55522A61K2039/55538
    • The present invention pertains to methods and pharmaceutical compositions for modulating an immune response. The method of the present invention involves administration of an effective amount of nucleic acid molecules encoding interleukin-12 (IL-12), interferon-gamma (IFN-γ), or a combination thereof, to a patient in need of such treatment. The pharmaceutical compositions of the invention contain nucleic acid molecules encoding IL-12 and/or IFN-γ and an operably-linked promoter sequence. In another aspect, the present invention concerns expression vectors containing a nucleotide sequence encoding IL-12 and IFN-γ, and an operably-linked promoter sequence. In another aspect, the present invention concerns cells generally modified with a nucleotide sequence encoding IL-12 and IFN-γ.
    • 本发明涉及用于调节免疫应答的方法和药物组合物。 本发明的方法涉及向需要这种治疗的患者施用有效量的编码白细胞介素-12(IL-12),干扰素-γ(IFN-γ)或其组合的核酸分子。 本发明的药物组合物含有编码IL-12和/或IFN-γ的核酸分子和可操作地连接的启动子序列。 另一方面,本发明涉及含有编码IL-12和IFN-γ的核苷酸序列和可操作地连接的启动子序列的表达载体。 另一方面,本发明涉及用编码IL-12和IFN-γ的核苷酸序列遗传修饰的细胞。